A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)

Inclusion Criteria:

- Mild to moderate male pattern baldness (androgenic alopecia) with ongoing hair loss
for at least 1 year

- Willingness to maintain same hair style, length and hair color during study

- Willingness to have micro-dot-tattoo applied to scalp (Stage 2 only)

Exclusion Criteria:

- Drug or alcohol abuse within 12 months

- HIV positive

- Received hair transplants or had scalp reductions

- Use of hair weaves, hair extensions or wigs within 3 months

- Use of minoxidil (oral or topical) and/or low level light treatment "combs" for hair
growth within the last 6 months, or expected use during the study

- Application of topical steroids or nonsteroidal anti-inflammatory drugs (NSAIDs) to
scalp within 4 weeks